Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKenmare Resources Regulatory News (KMR)

Share Price Information for Kenmare Resources (KMR)

Share Price is delayed by 15 minutes
Get Live Data
185.00    4.20 (2.32%)
Bid:
185.20
Ask:
188.00
Spread: 2.80 (1.512%)
Market Cap: £164.00m
KMR Live PriceLast checked at - London Stock Exchange

Intraday Kenmare Resources Share Chart

Form 8.3 - Kenmare Resources plc (replacement)

25 Jun 2025 09:44

RNS Number : 3542O
Perpetual Limited
25 June 2025
 

RNS number 1905O, released at 11:20 on 24/06/2025 was released in error. Please disregard.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ITPFIFSTRFIEFIE
Date   Source Headline
16th Aug 20237:00 amGNWDirector/PDMR Shareholding
15th Aug 20237:00 amGNWHalf-year report
15th Aug 20237:00 amGNWTender Offer
13th Jul 20237:00 amGNWQ2 and H1 2023 Production Report
3rd Jul 20233:15 pmGNWBoard Update
29th May 20237:00 amGNWDirector/PDMR Shareholding
11th May 20233:06 pmGNWResult of AGM
11th May 20233:03 pmGNWHolding(s) in Company
11th May 20237:00 amGNWReport on Payments to Governments
11th May 20237:00 amGNWBoard Update
5th May 20235:11 pmGNWHolding(s) in Company
2nd May 202312:06 pmGNWHolding(s) in Company
26th Apr 20237:00 amGNWCapital Markets Day
18th Apr 202312:00 pmGNWNotice of AGM
12th Apr 202312:00 pmGNWDirector/PDMR Shareholding
12th Apr 20237:00 amGNWQ1 2023 Production Report
11th Apr 20239:27 amGNWDirector/PDMR Shareholding
6th Apr 20237:00 amGNWPublication of 2022 Sustainability Report
6th Apr 20237:00 amGNWPublication of 2022 Annual Report
28th Mar 20234:30 pmGNWDirector/PDMR Shareholding
23rd Mar 20232:13 pmGNWHolding(s) in Company
22nd Mar 20237:00 amGNW2022 Preliminary Results
14th Mar 20231:16 pmGNWHolding(s) in Company
13th Mar 20232:04 pmGNWHolding(s) in Company
27th Feb 20239:56 amGNWHolding(s) in Company
27th Feb 20239:54 amGNWHolding(s) in Company
26th Jan 20237:00 amGNWBoard Update
18th Jan 20237:00 amGNWQ4 2022 Production Report and 2023 Guidance
16th Jan 20236:08 pmGNWHolding(s) in Company
9th Jan 20234:21 pmGNWHolding(s) in Company
9th Jan 20233:56 pmGNWHolding(s) in Company
22nd Dec 20224:35 pmGNWHolding(s) in Company
21st Dec 20225:07 pmGNWHolding(s) in Company
14th Dec 20227:00 amGNWBoard Update
1st Dec 20222:12 pmGNWDeirdre Somers appointed independent director of Enfusion, Inc.
25th Nov 20227:00 amGNWGuidance Update
9th Nov 20221:06 pmGNWHolding(s) in Company
18th Oct 20224:43 pmGNWHolding(s) in Company
14th Oct 202211:54 amGNWHolding(s) in Company
13th Oct 20227:00 amGNWQ3 2022 Production Report
4th Oct 20229:03 amGNWResults of Odd-lot Offer
30th Sep 202212:18 pmGNWDirector/PDMR Shareholding
30th Sep 20227:00 amGNWBoard Update
28th Sep 20221:45 pmGNWDirector/PDMR Shareholding
26th Sep 20222:22 pmGNWHolding(s) in Company
31st Aug 20224:01 pmGNWHolding(s) in Company
25th Aug 20227:00 amGNWAppointment of Financial Director / Directorate Change Announcement under LR 9.6.11
24th Aug 20227:00 amGNWLaunch of Odd-lot Offer and Finalisation of Offer Price
19th Aug 20224:44 pmGNWHolding(s) in Company
17th Aug 20227:00 amGNWHalf-Yearly Financial Report for the six months to 30 June 2022 and interim dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.